Answers are grounded in this paper and cite their sources.
Longitudinal cohort study reveals that EEG functional connectivity predicts adaptive function changes in autistic youth, indicating its utility as a prognostic biomarker.
Many autistic people have challenges with adaptive function, impacting education, employment and independent-living goals. Adaptive function outcomes of autistic people vary considerably, which makes planning for future needs challenging. Here, using a developmentally sensitive approach, we investigated if cortico-cortical functional connectivity – a core neurobiological feature that differs in autism – could predict longitudinal changes in adaptive function in autistic people. Using electroencephalography in 150 autistic and 159 non-autistic participants aged 6–31 years, we investigated if mean degree and network organisation (small-world index) predict longitudinal changes in adaptive function over 19-months. We found that small-world index significantly predicted changes in adaptive function in autistic people across the entire age-range. Predictive performance was best for autistic youth (15–24-year-olds), where mean degree and small-world index explained 21 and 30% of additional variance in outcomes, respectively, outperforming measures of intelligence and autistic features. In categorising binary (improved versus not-improved) outcomes, the model containing mean degree had an AUC of 0.84 [95% CI: 0.71–0.97] in 15–24-year-olds, while that containing small-world index had an AUC of 0.76 [95% CI: 0.63–0.89] across the 6–31-year age-range. Both metrics demonstrated properties desired in prognostic biomarkers: high test-retest reliability and convergence with underlying biology (significant associations with genetic variation in brain volume-related genes). Thus, we demonstrate the first evidence that electroencephalography-derived functional connectivity metrics show promise as prognostic biomarkers of adaptive function in autistic people. Potential precision-medicine applications include stratifying participants in clinical trials and identifying those at risk of declining function in clinical settings.
No takes yet. Share an insight, caveat, or question.
Mehra et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: